Investor interest in Indian deeptech startups like space, biotech, and hardware is rising due to government support and better local capital availability. However, founders warn that investors should avoid 'Fear Of Missing Out' (FOMO) when funding these companies, as they require much longer timeframes to show results compared to software startups.
Detailed Coverage
Investor appetite for India’s deeptech sector, covering areas like space technology, advanced manufacturing, and biotechnology, has seen a notable rise. This shift reflects a move away from the traditional dominance of software-focused startups toward businesses building complex, foundational technologies. At the recent Rising Bharat Summit, industry leaders shared how the perception of Indian hardware and deeptech ventures has changed significantly over the last decade.
Why Investors Are Moving Toward Deeptech
The increased funding is largely driven by a combination of government policy support and a growing pool of patient capital—investments meant for long-term growth rather than quick exits. Founders pointed out that India’s historical reliance on importing critical technologies is creating a massive market for domestic solutions. For example, space tech and gene therapy companies are now finding it easier to secure funding from local venture capital firms, a sign that the Indian startup ecosystem is maturing toward solving complex, high-stakes problems.
The Risk of Long Gestation Periods
While the sector is growing, startup leaders are advising investors to be careful. A major risk in deeptech is the development timeline. Unlike software companies, which can scale rapidly with minimal physical infrastructure, deeptech firms often spend years on research, prototyping, and testing before reaching commercial production. Founders at the summit warned that some investments are currently being driven by a fear of missing out, or FOMO. If investors treat deeptech startups like software companies—expecting fast growth and immediate revenue—they may face disappointment when the projects take longer to mature.
What Investors Should Track Next
For those interested in this space, the primary monitorable is the execution timeline of these companies. Investors should look for businesses that have clearly defined milestones for research, regulatory approvals, and pilot projects. The success of these firms will likely depend on their ability to manage cash flow through long development cycles, the effectiveness of the government’s Research, Development and Innovation (RDI) Fund, and the ability of founders to deliver on technical goals without burning through capital too quickly. Tracking how these startups transition from the lab to market will be crucial for understanding which ventures can sustain their growth.